Sort
39,280 grants matching “leukemia”
Cheap and fast ambient air monitoring of pesticides
$489,002Nuria Queralto-Gratacos · Isense, Llc · R44 · FY2015 · ES
The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia
$488,809Jian Huang · Coriell Institute For Medical Research · R01 · FY2024 · HL
EARLY DETECTION OF CLONAL HEMATOPOIESIS AND LEUKEMIA ASSOCIATED MUTATIONS IN WTC EXPOSED FIREFIGHTERS AFTER THE 9/11 ATTACKS
$488,696Amit Verma · Albert Einstein College Of Medicine · U01 · FY2021 · OH
The cohesin complex as a tumor suppressor in myeloid leukemia
$488,648Iannis Aifantis · New York University School Of Medicine · R01 · FY2021 · CA
Regulation of Mast Cell Proteases
$488,644Richard L Stevens · Brigham And Women'S Hospital · P01 · FY2008 · HL
Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection
$488,643Todd M Allen · Massachusetts General Hospital · R37 · FY2022 · AI
EARLY DETECTION OF CLONAL HEMATOPOIESIS AND LEUKEMIA ASSOCIATED MUTATIONS IN WTC EXPOSED FIREFIGHTERS AFTER THE 9/11 ATTACKS
$488,632Amit Verma · Albert Einstein College Of Medicine · U01 · FY2023 · OH
EARLY DETECTION OF CLONAL HEMATOPOIESIS AND LEUKEMIA ASSOCIATED MUTATIONS IN WTC EXPOSED FIREFIGHTERS AFTER THE 9/11 ATTACKS
$488,632Amit Verma · Albert Einstein College Of Medicine · U01 · FY2022 · OH
Characterizing noncoding GWAS variants in acute lymphoblastic leukemia treatment outcome
$488,482Daniel Savic · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Dual Kinase and LSD1 Inhibition in Acute Myeloid Leukemia
$488,445Theodore Paul Braun · Oregon Health & Science University · R01 · FY2024 · CA
Mechanism of Therapy in high-risk AML
$488,415Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
Mechanism of Therapy in high-risk AML
$488,415Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL
$488,414Nadia Carlesso · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias
$488,387Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Regulation Of Immune Responses In Humans and in Experimental Animals
$488,334Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
$488,229Craig Alan Byersdorfer · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
$488,229Craig Alan Byersdorfer · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
$488,229Heth R. Turnquist · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
$488,229Craig Alan Byersdorfer · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · HL
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
$488,229Craig Alan Byersdorfer · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HL
NIH Myeloid Malignancy Program
$488,202Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases
$488,202Sankar Adhya · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
NHGRI/DIR Zebrafish Core
$488,186David M. Bodine · National Human Genome Research Institute · Z01 · FY2008 · HG
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
$488,185Giovanna Tosato · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Chromatin Insulators for Human Gene Therapy
$488,180George Stamatoyannopoulos · University Of Washington · P01 · FY2010 · HL